Antineoplastics Encapsulated in Nanostructured Lipid Carriers
Ideally, antineoplastic treatment aims to selectively eradicate cancer cells without causing systemic toxicity. A great number of antineoplastic agents (AAs) are available nowadays, with well-defined therapeutic protocols. The poor bioavailability, non-selective action, high systemic toxicity, and l...
Guardado en:
Autores principales: | Gustavo Henrique Rodrigues da Silva, Ludmilla David de Moura, Fabíola Vieira de Carvalho, Gabriela Geronimo, Talita Cesarim Mendonça, Fernando Freitas de Lima, Eneida de Paula |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/43bf0933d3f9401a9fe846784f1432e2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Acute and subacute toxicity profiles of thymoquinone-loaded nanostructured lipid carrier in BALB/c mice
por: Ong YS, et al.
Publicado: (2016) -
Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis
por: Deng J, et al.
Publicado: (2020) -
Pharmacokinetics and Biodistribution of Thymoquinone-loaded Nanostructured Lipid Carrier After Oral and Intravenous Administration into Rats
por: Zakarial Ansar FH, et al.
Publicado: (2020) -
Mucoadhesive, Thermoreversible Hydrogel, Containing Tetracaine-Loaded Nanostructured Lipid Carriers for Topical, Intranasal Needle-Free Anesthesia
por: Giovana Maria Fioramonti Calixto, et al.
Publicado: (2021) -
Annatto Oil Loaded Nanostructured Lipid Carriers: A Potential New Treatment for Cutaneous Leishmaniasis
por: Marianna Araújo Ferreira, et al.
Publicado: (2021)